Table 1.
Current ART drug availability in China
| Drug class | Available in China | Not available in China | |
|---|---|---|---|
| Free | Not free | ||
| NRTIs |
Lamivudine (3TC) Tenofovir (TDF) Zidovudine (AZT) Abacavir (ABC) |
Emtricitabine (FTC) Tenofovir Alafenamide (TAF) |
|
| NNRTIs |
Efavirenz (EFV) Nevirapine (NVP) |
Rilpivirine (RPV) Etravirine (ETV) |
Doravirine (DOR) |
| PIs | Lopinavir/ritonavir (LPV/r) |
Darunavir/cobicistat (DRV/c) Atazanavir (ATV) |
Fosamprenavir (FPV) Nelfinavir (NFV) Saquinavir (SQV) Tipranavir (Aptivus) |
| INSTIs |
Raltegravir (RAL) Dolutegravir (DTG) |
Bictegravir (BIC) Elvitegravir (EVG) |
|
| Fusion inhibitor | Albuvirtide | Enfuvirtide (T20) | |
| CCR5 antagonist | Maraviroc (MVC) | ||
| Co-formulated fixed-dose | AZT/3TC |
FTC/TDF FTC/TAF AZT/3TC/ABC ABC/3TC/DTG TAF/FTC/EVG/c |
BIC/TAF/FTC EVG/c/TDF/FTC DTG/3TC DRV/c/TAF/FTC EFV/TDF/FTC RPV/TDF/FTC |